...
首页> 外文期刊>BMC Cancer >Protocol of the Italian Radical Cystectomy Registry (RIC): a non-randomized, 24-month, multicenter study comparing robotic-assisted, laparoscopic, and open surgery for radical cystectomy in bladder cancer
【24h】

Protocol of the Italian Radical Cystectomy Registry (RIC): a non-randomized, 24-month, multicenter study comparing robotic-assisted, laparoscopic, and open surgery for radical cystectomy in bladder cancer

机译:意大利自由基膀胱切除术登记处的协议(RIC):非随机化,24个月,多中心研究比较膀胱癌激进膀胱切除术的机器人辅助,腹腔镜和开放手术

获取原文
           

摘要

Bladder cancer is the ninth most common type of cancer worldwide. In the past, radical cystectomy via open surgery has been considered the gold-standard treatment for muscle invasive bladder cancer. However, in recent years there has been a progressive increase in the use of robot-assisted laparoscopic radical cystectomy. The aim of the current project is to investigate the surgical, oncological, and functional outcomes of patients with bladder cancer who undergo radical cystectomy comparing three different surgical techniques (robotic-assisted, laparoscopic, and open surgery). Pre-, peri- and post-operative factors will be examined, and participants will be followed for a period of up to 24?months to identify risks of mortality, oncological outcomes, hospital readmission, sexual performance, and continence. We describe a protocol for an observational, prospective, multicenter, cohort study to assess patients affected by bladder neoplasms undergoing radical cystectomy and urinary diversion. The Italian Radical Cystectomy Registry is an electronic registry to prospectively collect the data of patients undergoing radical cystectomy conducted with any technique (open, laparoscopic, robotic-assisted). Twenty-eight urology departments across Italy will provide data for the study, with the?recruitment phase between 1st January 2017-31st October 2020. Information is collected from the patients at the moment of surgical intervention and during follow-up (3, 6, 12, and 24?months after radical cystectomy). Peri-operative variables include surgery time, type of urinary diversion, conversion to open surgery, bleeding, nerve sparing and lymphadenectomy. Follow-up data collection includes histological information (e.g., post-op staging, grading, and tumor histology), short- and long-term outcomes (e.g., mortality, post-op complications, hospital readmission, sexual potency, continence etc). The current protocol aims to contribute additional data to the field concerning the short- and long-term outcomes of three different radical cystectomy surgical techniques for patients with bladder cancer, including open, laparoscopic, and robot-assisted. This is a comparative-effectiveness trial that takes into account a complex range of factors and decision making by both physicians and patients that affect their choice of surgical technique. ClinicalTrials.gov , NCT04228198 . Registered 14th January 2020- Retrospectively registered.
机译:膀胱癌是全世界第九次常见的癌症。过去,通过开放手术的自由基膀胱切除术被认为是肌肉侵袭性膀胱癌的金标准治疗。然而,近年来,使用机器人辅助腹腔镜自由基膀胱切除术逐渐增加。目前项目的目的是探讨膀胱癌患者的手术,肿瘤和功能结果,患有三种不同手术技术(机器人辅助,腹腔镜和开放手术)的激进膀胱切除术。将进行审查,佩密和术后因素,参与者将被遵循高达24个月的时间,以确定死亡率,肿瘤成果,医院入院,性绩效和持续性的风险。我们描述了一个用于观察,前瞻性,多中心的群组研究的协议,以评估受膀胱肿瘤影响的患者进行自由基膀胱切除术和尿液转移。意大利自由基膀胱切除术登记处是一种电子注册表,用于预期收集经受任何技术进行自由基膀胱切除术的患者的数据(开放,腹腔镜,机器人辅助)。意大利的二十八个泌尿外科部门将为这项研究提供数据,其中包含2017-31年10月1日1日1月1日之间的招聘阶段。在手术干预和随访期间从患者收集信息(3,6, 12和24个月后膀胱切除术后的月份)。 Peri-ilical的变量包括手术时间,尿液转移类型,转化为开放手术,出血,神经备件和淋巴结切除术。后续数据收集包括组织学信息(例如,OP,分级,分级和肿瘤组织学),短期和长期结果(例如,死亡率,op后并发症,医院入院,性效力,大陆等)。目前的协议旨在为膀胱癌患者提供额外的数据,包括三种不同自由基膀胱切除术外科手术技术的短期和长期结果,包括开放,腹腔镜和机器人辅助。这是一个比较有效性试验,考虑到了影响他们选择手术技术的医生和患者的复杂因素和决策。 ClinicalTrials.gov,NCT04228198。注册2020年1月14日 - 回顾性注册。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号